Form 4: Xencor CFO Bart Jan Cornelissen Reports Acquisition of Stock and Stock Options

Bart Jan Cornelissen, CFO of Xencor, Inc., reports the acquisition of common stock and stock options, as well as the disposal of common stock.

Summary

• On March 4, 2025, Bart Jan Cornelissen, the Senior Vice President & CFO of Xencor Inc., reported transactions involving the company's securities.
• Cornelissen acquired 21,949 shares of common stock at $0 and disposed of 884 shares.
• Following these transactions, Cornelissen beneficially owns 65,098 shares of common stock.
• Cornelissen also acquired 65,847 stock options with an exercise price of $14.15, exercisable starting March 4, 2026, and expiring on March 4, 2035.
• A power of attorney was executed on February 19, 2025, granting authority to Bassil I. Dahiyat, Bart Jan Cornelissen, and Celia E. Eckert to execute Forms 3, 4, 5, and 144 on behalf of the reporting person.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and stock options by the CFO suggests confidence, but the disposal of some shares tempers the positive outlook.

Positives

• The acquisition of stock options and shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of 884 shares could be interpreted negatively, although the overall increase in holdings suggests a positive outlook.

Risks

• Executive stock transactions are subject to market fluctuations and regulatory scrutiny.
• Changes in company performance or market conditions could impact the value of the acquired stock and options.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the executive's increased investment suggests a positive outlook.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• Vesting schedules for stock options are typically structured to incentivize long-term commitment and performance.
• Similar to other biotechnology companies, Xencor uses equity-based compensation to attract and retain key personnel.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment, reflecting confidence from a key executive.
• The vesting schedule of the stock options incentivizes the CFO to remain with the company, benefiting employees and shareholders.

Key Dates